AJPH First Look, published online ahead of print Jun 28, 2005
HIV Incidence Among Injection Drug Users in New York City, 1990 to 2002: Use of Serologic Test Algorithm to Assess Expansion of HIV Prevention Services
Don C. Des Jarlais, PhD,
Theresa Perlis, PhD,
Kamyar Arasteh, PhD,
Lucia V. Torian, PhD,
Sara Beatrice, PhD,
Judith Milliken, BA,
Donna Mildvan, MD,
Stanley Yancovitz, MD and
Samuel R. Friedman, PhD
At the time the research was completed, Don C. Des Jarlais, Theresa Perlis, Judith Milliken, Donna Mildvan, and Stanley Yancovitz were with Beth Israel Medical Center, New York, NY; Lucia V. Torian and Sara Beatrice were with the New York City Department of Health and Mental Hygiene; and Kamyar Arasteh and Samuel R. Friedman were with the National Development and Research Institutes, New York, NY.

View larger version (9K):
[in a new window]
|
FIGURE 1— HIV incidence among injection drug users entering Beth Israel Medical Center drug detoxification program, New York City, 19902002.
Note. T bars denote 95% confidence intervals.
|
|

View larger version (9K):
[in a new window]
|
FIGURE 2— Annual mean number of syringes exchanged by programs in New York City, 19902002.
Note. Other services provided at syringe exchanges also expanded during this time period.
|
|
Copyright © 2005 by the American Public Health Association